Additional studies have shown that verteporfin delays the progression of osteosarcoma in Ctsk-Cre; Trp53f/f/Rb1f/f mice by inhibiting YAP/TAZ and preventing bone erosion, providing new possibilities for the treatment of osteosarcoma (Li, Yang & Yang, 2022). Here, YAP1 is linked to osteosarcoma.